Cassava Sciences (ticker: SAVA) has the safe and effective solution to Alzheimer’s disease now in phase 3 trials. Stock analyst Joe Springer narrates doctors and patient testimonials.
Directed by Paul Efron (USA)
SAVA Cassava Doctor/Family Testimonials